Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Showa Nosan Kako Co., Ltd. is a Japanese manufacturing company specializing in the production of high-purity crystalline fructose and other agricultural-derived ingredients. As a subsidiary of Showa Sangyo, the company leverages advanced enzymatic processing and purification technologies to serve the food, beverage, and pharmaceutical industries. In the healthcare sector, Showa Nosan Kako provides pharmaceutical-grade excipients used in the formulation of oral medications and intravenous infusions. Their products are particularly significant in medical nutrition and as specialized sweeteners for patients with metabolic requirements, such as those with diabetes. The company maintains rigorous quality control to meet the standards required for medical-grade applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Showa Nosan Kako.